REVB Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 mai 2024 @ 22:00):

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics...

Stats
Dagens volum	21 219.00
Gjennomsnittsvolum	181 011
Markedsverdi	3.59M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-5.39 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.15
ATR14	$0.0280 (1.27%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-08	Tidmarsh George F	Sell	27 771	Common Stock
2023-10-16	Tidmarsh George F	Sell	1 845	Common Stock
2023-10-16	Tidmarsh George F	Sell	10 957	Common Stock
2023-09-27	Chawla Lakhmir S	Buy	0
2023-09-28	Tidmarsh George F	Sell	1 429	Common Stock

INSIDER POWER
-13.05
Last 48 transactions
Buy: 316 523 \| Sell: 2 020 596

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: 0.46 (neutral)

Signal:(35.617) Neutral

Revelation Biosciences, Korrelasjon

10 Mest positive korrelasjoner
KBNT	0.979
KSPN	0.979
VRM	0.976
CSSEN	0.974
IRBT	0.972
RDHL	0.962
AHPI	0.961
AXDX	0.96
IDBA	0.958
TKLF	0.957

10 Mest negative korrelasjoner
NVCN	-0.98
ROVR	-0.979
AVEO	-0.979
ITMR	-0.974
DVCR	-0.968
ATVI	-0.967
STAY	-0.966
INBK	-0.961
HCCI	-0.96
ADTH	-0.96

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Revelation Biosciences, Korrelasjon - Valuta/Råvare

0.56
( weak )

0.18
( neutral )

0.00
( neutral )

0.12
( neutral )

-0.08
( neutral )

-0.25
( neutral )

Revelation Biosciences, Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-25 049.00 (0.00 %)
EPS:	$-0.530

FY	2023
Omsetning:	$0
Bruttogevinst:	$-25 049.00 (0.00 %)
EPS:	$-0.530

FY	2022
Omsetning:	$0
Bruttogevinst:	$-40 008.00 (0.00 %)
EPS:	$-600.77

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.310

Financial Reports:

No articles found.

Revelation Biosciences,

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.